RLYB (rallybio.com) Sof foyda

Rallybio Corporation (RLYB) korporativ emblemasi va logotipi

Kamyob kasalliklar dori vositalariga bo'lgan monopolistik talab Rallybio Corporation (RLYB) uchun uzoq muddatli superfoydalarni kafolatlaydi. GURU.Markets kotirovkalari tomonidan shakllantirilgan kompaniyaning moliyaviy natijalari ushbu tendentsiyani aniq ko'rsatadi, 0.03 esa ushbu baholash parametrini tavsiflaydi. Biznes ustunligi qon patologiyalari uchun eksklyuziv davolash usullariga asoslangan; biroq, yuqori tadqiqot xarajatlari va klinik muvaffaqiyatsizliklar xavfi kapitalga bosim o'tkazmoqda.

RLYB (rallybio.com) Kompaniyaning sof foydasi tarixi 04.07.2022dan 01.11.2026gacha

rallybio.com (RLYB) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Rallybio|RLYB - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Rallybio Corporation|RLYB - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Rallybio|RLYB - Kompaniyaning balans qiymati|Bozor qiymatining balans qiymatiga koeffitsiyenti rallybio.com|RLYB - Kompaniyaning yakuniy aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Jamlagan qarzning kapitalga nisbati Rallybio Corporation|RLYB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Rallybio|RLYB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Rallybio Corporation|RLYB - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Rallybio|Oraliq qoplash koeffitsiyenti rallybio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
RLYB - Sof foyda
Fundamental baholash:RLYB Rallybio Corp.
Rallybio Corp yetakchi tovari

Biotehnologiya sektori uchun Rallybio Corporation (RLYB) moliyaviy foydasi jami daromaddan barcha operatsion va soliq xarajatlari chegirilgandan keyingi sof naqd pul balansini aks ettiradi. Ushbu ko'rsatkichning tendentsiyasi dori vositalari tijoratlashtirilishidan oldin kapitalni boshqarish samaradorligi va likvidlilik rezervlarini baholash imkonini beradi, bu esa foyda tahlilini barqaror pul oqimi mavjud bo'lmagan sharoitda biznesning barqarorligini monitoring qilish vositasiga aylantiradi.

Asosiy raqobatchilar

Sof daromad Haleon Corp|KVUE (Kenvue Inc.) - Sof foyda|Sof foyda veronapharma.com|Sof daromad MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Yakuniy foyda|Kompaniyaning sof foydasi Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Kompaniyaning sof daromadi|ALVO: Sof daromad|liquidia.com - Soliqlar to‘langandan keyingi foyda|GLPG: Sof foyda|ANI Pharmaceuticals Inc - Yakuniy foyda|MNKD (MannKind Corp.) - Sof foyda|Kompaniyaning sof daromadi Amphastar Corp AMPH|Kompaniyaning sof foydasi Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Yakuniy foyda|Kompaniyaning sof foydasi Theravance Biopharma, Inc. TBPH|Yakuniy foyda AQST|scPharma - Sof foyda|TECX - Sof foyda|Tonix Pharmaceuticals (TNXP) - Kompaniyaning sof foydasi|SXTC (China SXT Pharmaceuticals, Inc.) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Eupraxia Pharmaceuticals, Inc.|Kompaniyaning sof foydasi BHST|Sof daromad EXOZ (Invizyne Technologies, Inc.)|ORMP - Kompaniyaning sof daromadi|Sof foyda ENTX (Entera Bio)|ipatherapeutics.com - Kompaniyaning sof foydasi|ABVC BioPharma, Inc. - Sof foyda|Sof moliyaviy natija Cumberland Pharmaceuticals Inc CPIX|Quantum BioPharma Limited (QNTM) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi FibroGen Corporation (FGEN)|Sof daromad TELO|RANI: Yakuniy foyda|Sof foyda SNYR|Sof daromad lexariabioscience.com LEXX|Kompaniyaning sof foydasi Pulmatrix Corp PULM|Pheton Holdings Limited (PTHL) - Kompaniyaning sof daromadi|APM - Kompaniyaning sof foydasi|Yakuniy foyda LYRA (lyratherapeutics.com)|Impact BioMedical Inc (IBO) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda TNFA (TNF Pharmaceuticals, Inc.)|Kompaniyaning sof foydasi cbdMD Inc.|Kompaniyaning sof daromadi PainReform Corp PRFX|Kompaniyaning sof foydasi Altamira Therapeutics (CYTO)|LIPO (lipella.com) - Yakuniy foyda|Sof foyda OPTN (OptiNose)|Sof foyda Pieris Pharmaceuticals Inc PIRS|PROC: Sof daromad|Petros Pharma - Soliqlar to‘langandan keyingi foyda|QLI: Sof foyda|SLRN - Sof moliyaviy natija|Kompaniyaning sof foydasi TFF Pharmaceuticals, Inc.